INNOVADERM CRO IS NOW INDERO.

Dupilumab inhibits vascular leakage of blood proteins into atopic dermatitis skin

Date: 2023-13-06 Authors: Leung DYM, Bissonnette R, Kreimer S, Berdyshev E, Bafna S, Lyubchenko T, Richers BN, Garcia S, Ramirez-Gama M, Hall CF, Xiao O, Taylor P, Boguniewicz M, Levit NA, Agueusop I, Zhang A, Goleva E Category: Dermatitis (all types) Conflict of interest statement: Conflicts of interest The full list is provided in Appendix […]

The Treat-to-Target Project in Atopic Dermatitis: One Year On

Date: 2023-21-04 Authors: De Bruin-Weller M, Deleuran M, Biedermann T, Bissonnette R, Foley P, Girolomoni G, HercogovĂĄ J, Hong CH, Katoh N, Pink A, Richard MA, Shumack S, Silvestre JF, Thyssen JP, Weidinger S Category: Dermatitis (all types) Conflict of interest statement: Conflicts of interest The full list is provided in Appendix S1 (see Supporting […]

Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome towards nonlesional and normal skin

Date: 2023-11-04 Authors: Madeline Kim, Ester Del Duca, Julia Cheng, Britta Carroll, Paola Facheris, Yeriel Estrada, Amy Cha, John Werth, Robert Bissonnette, Karl Nocka, Chuanbo Zang, Ana B Pavel, Emma Guttman-Yassky Category: Dermatitis (all types) Conflict of interest statement: Conflicts of interest The full list is provided in Appendix S1 (see Supporting Information). Read more […]

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.